Literature DB >> 34350701

Upsurge of human rhinovirus infection followed by a delayed seasonal respiratory syncytial virus infection in Thai children during the coronavirus pandemic.

Ilada Thongpan1, Preeyaporn Vichaiwattana1, Sompong Vongpunsawad1, Yong Poovorawan1.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) and human rhinovirus (HRV) commonly cause influenza-like illness in young children. The global coronavirus pandemic beginning in 2020 altered the seasonality and prevalence of these respiratory infections in Thailand. We aimed to characterize the upsurge of HRV and the subsequent RSV infection observed among young children who sought medical care at a hospital in Bangkok.
METHODS: From July to December 2020, nasopharyngeal swabs from children ≤5 years of age presented with influenza-like illness were tested for RSV and HRV using reverse-transcription polymerase chain reaction. Positive samples were Sanger sequenced. Genotyping was performed using sequence and phylogenetic analysis.
RESULTS: Upsurge of HRV infection began in July and was subsequently replaced by a surge of RSV infection from September onward. In 6 months, HRV was detected in 27.5% (158/574) of the samples, of which 44% (69/158) were HRV-A, 7% (11/158) were HRV-B, and 36% (57/158) were HRV-C. Meanwhile, RSV was detected in 40.4% (232/574) of the samples, of which 78% (181/232) were RSV-A and 6% (14/232) were RSV-B. RSV peaked in October 2020, approximately 2 months later than typically seen in previous years. All RSV-A were of subgenotype ON1. Codetection of HRV and RSV was found in 5.1% (29/574).
CONCLUSIONS: HRV and RSV infection among young children coincided with relaxed local coronavirus public health measures, including the return to in-class schooling. The delayed RSV season in 2020 was predominantly associated with RSV-A.
© 2021 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.

Entities:  

Keywords:  children; coronavirus; infection; respiratory syncytial virus; rhinovirus

Year:  2021        PMID: 34350701     DOI: 10.1111/irv.12893

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


  6 in total

1.  Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic.

Authors:  You Li; Xin Wang; Bingbing Cong; Shuyu Deng; Daniel R Feikin; Harish Nair
Journal:  J Infect Dis       Date:  2022-03-15       Impact factor: 5.226

2.  Delayed respiratory syncytial virus outbreak in 2020 in Taiwan was correlated with two novel RSV-A genotype ON1 variants.

Authors:  Chun Yi Lee; Tsung Hua Wu; Yu Ping Fang; Jih Chin Chang; Hung Chun Wang; Shou Ju Lin; Chen Hao Mai; Yu Chuan Chang; Teh Ying Chou
Journal:  Influenza Other Respir Viruses       Date:  2021-12-16       Impact factor: 4.380

3.  SARS-CoV-2 in children and their accompanying caregivers: Implications for testing strategies in resource limited hospitals.

Authors:  Liezl Smit; Andrew Redfern; Sadia Murray; Juanita Lishman; Marieke M van der Zalm; Gert van Zyl; Lilly M Verhagen; Corné de Vos; Helena Rabie; Annemarie Dyk; Mathilda Claassen; Jantjie Taljaard; Marina Aucamp; Angela Dramowski
Journal:  Afr J Emerg Med       Date:  2022-04-25

4.  Viral infections in hospitalized children in Germany during the COVID-19 pandemic: Association with non-pharmaceutical interventions.

Authors:  Nicolas Terliesner; Nadine Unterwalder; Anke Edelmann; Victor Corman; Andreas Knaust; Leonard Rosenfeld; Alexander Gratopp; Hannelore Ringe; Luise Martin; Horst von Bernuth; Marcus A Mall; Tilmann Kallinich
Journal:  Front Pediatr       Date:  2022-08-11       Impact factor: 3.569

5.  International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures.

Authors:  Marie-Noëlle Billard; Peter M van de Ven; Bianca Baraldi; Leyla Kragten-Tabatabaie; Louis J Bont; Joanne G Wildenbeest
Journal:  Influenza Other Respir Viruses       Date:  2022-06-22       Impact factor: 5.606

Review 6.  The effects of the COVID-19 pandemic on community respiratory virus activity.

Authors:  Eric J Chow; Timothy M Uyeki; Helen Y Chu
Journal:  Nat Rev Microbiol       Date:  2022-10-17       Impact factor: 78.297

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.